NCT03498079

Brief Summary

  • Mullerian anomalies are congenital structural anomalies in the uterus .
  • Its prevalence is not uncommon .

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
250

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Apr 2018

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 7, 2018

Completed
6 days until next milestone

First Posted

Study publicly available on registry

April 13, 2018

Completed
3 days until next milestone

Study Start

First participant enrolled

April 16, 2018

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 20, 2019

Completed
5 days until next milestone

Study Completion

Last participant's last visit for all outcomes

April 25, 2019

Completed
Last Updated

January 9, 2019

Status Verified

January 1, 2019

Enrollment Period

1 year

First QC Date

April 7, 2018

Last Update Submit

January 8, 2019

Conditions

Outcome Measures

Primary Outcomes (1)

  • the number of participants who will prove to have PCO

    diagnosis of PCO by US and by FSH and LH levels

    within 4 weeks

Interventions

3D ultrasoundDIAGNOSTIC_TEST

3D ultrasound will be done to females complaining from primary infertility with mullerian anomalies

Eligibility Criteria

Age20 Years - 40 Years
Sexfemale(Gender-based eligibility)
Gender Eligibility Detailsfemales with primary infertility
Healthy VolunteersYes
Age GroupsAdult (18-64)
Sampling MethodProbability Sample
Study Population

\- females with age between 20-42 years with primary infertility

You may qualify if:

  • females with age between 20-42 years with primary infertility

You may not qualify if:

  • females with age above 42 years or below 20 years females with secondary infertility

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Algazeerah

Giza, Egypt

RECRUITING

Study Officials

  • Mahmoud Alalfy

    Algazeerah hospital -Location (Giza -Egypt ) and National Research centre egypt

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
PROSPECTIVE
Target Duration
4 Weeks
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Researcher , National Research centre and Specialist of Obstetrics and Gynecology in Aljazeerah hospital

Study Record Dates

First Submitted

April 7, 2018

First Posted

April 13, 2018

Study Start

April 16, 2018

Primary Completion

April 20, 2019

Study Completion

April 25, 2019

Last Updated

January 9, 2019

Record last verified: 2019-01

Data Sharing

IPD Sharing
Will not share

we will publish the results which will be obtained from this study

Locations